|Day Low/High||163.90 / 164.95|
|52 Wk Low/High||109.16 / 165.16|
High-quality drugmaker AbbVie has several promising products aside from Humira and the market has priced the stock at a bargain.
Debt-free and poised to gain from its COVID-19 vaccine demand, MRNA could inject some life into your investment plan.
These Dividend Aristocrats have free DRIPs, long histories of raising their dividends, and attractive yields well above the market average.
The market seems to rejoice from the latest mask utterance out of the CDC, but the action at the Nasdaq should give traders pause.
ARCT's IP is incredibly valuable, and may in fact be invaluable.
UPS and FDX are both in serious rally mode, yet in very different places in terms of technical development.
When you hear about chip shortage you need to think of Lam. The world needs Lam to add to capacity as fast as possible.
Always, always, always stick to your rules. Always. This is why we have targets, pivots and panics.
The marketplace responded well to the first week of earnings season, or should we say what we saw beyond the banks that dominated.
It's easy to be caught on the wrong side of the rotations if you aren't careful.
Let's look at this impossible move on the market -- and why health care could be coming off life support.
How Interesting. On Wednesday, market participants rotated out of the un-rotation that had been in vogue for most of April.
Bitcoin, NFTs, ethereum or even the S&P are not what matters right now. They're simply a series of exciting developments that aren't putting people to work.
Perhaps the most interesting result of an inflationary but not frightening CPI was visible in U.S. Treasury security markets.
Here's how to play AAL as it's off because of vaccine news.
You never want to be caught in a counter trend rally.
These seven concerns are why I took money out of the market for my charitable trust.
The March CPI rose +0.6% month over month and +0.3% ex food and energy, both one tenth more than expected. These can't be explained away by easy comps. The easy comps are year over year where the headline increase was +2.6% and the core rate rose by...
Don't forget, this is a very large company with a lot more than the vaccine going on.
Some observations: * Ss over Ns. And the Russell is not crowing. (I added to my and shorts on the morning's strength). * Banks are lower in a sea of green this morning. It is my view that bank stocks are vulnerable after the runup. I will have a co...
I am (personally) shorting Delta Air Lines - above $48 - in premarket trading following the J&J vaccine news. DAL is on my Best Ideas List (short).
Stay focused on sectors and rotational action if you want to navigate the action.
Recently in "On The Market's Stairway to Heaven - Headwinds Abound" I wrote: "In all likelihood the groovy music being played in the market these days will be interrupted by something that could occur 'out of the blue' that no one is properly focus...
Break in! The U.S. will seek to pause Johnson & Johnson COVID vaccines owing to clotting issues. I have added to my personal index shorts.
I would argue that the pandemic has lasted just long enough to wipe out the little guy and let the bigger guys have the run of the joint.
The issue is when the data conflict with the prevailing narrative. We are in such a position now.
My COVID vaccine eligibility actually began about a week before my symptoms began.